Bortetrust – Bortezomib 2mg Injection
Description
BORTEZOMIB (BORTITRUST) INJECTION – TREATMENT FOR MULTIPLE MYELOMA AND MANTLE-CELL LYMPHOMA
Bortezomib or Bortetrust 2 Injection is a therapy for multiple myeloma and mantle cell lymphoma. It demonstrates its effectiveness by halting or reducing the growth of cancer cells.
Bortetrust 2 Injection is administered through injection by a trained medical expert. Your doctor will determine the appropriate dose and frequency of administration. This will vary depending on what you are being treated for and may alter over time.
When you have multiple myeloma, your body destroys bone quicker than it replaces it. This causes bones to become weak, painful, and prone to breaking. Bortetrust 2 Injection may be used in conjunction with other cancer treatments such as chemotherapy. It is an important aspect of your treatment and helps people with multiple myeloma live longer lives. This medication will eliminate the malignant cells and prevent them from growing and spreading to other places of the body. To get the most out of your medication, strictly follow your doctor’s directions. Calcium and Vitamin D3 supplements are also useful and may be administered if you do not have high blood calcium levels.
Fedelty Health Care is a Bortezomib wholesaler, Pharmaceutical Cargo Bulk Exporter & Hospital Supply.
USES OF BORTEZOMIB (BORTITRUST) INJECTION
- Multiple myeloma
- Mantle-cell lymphoma
WORKS OF BORTEZOMIB (BORTITRUST) INJECTION
Bortetrust 2 Injection is a cancer-fighting drug. It works by preventing or decreasing protein degradation in cells. As a result, a number of proteins in cancer cells rise, leading to their demise.
Fedelty Health Care is a Bortezomib wholesaler, Pharmaceutical Cargo Bulk Exporter & Hospital Supply.
SIDE EFFECTS OF BORTEZOMIB (BORTITRUST) INJECTION
The majority of adverse effects do not necessitate medical treatment and will go away as your body adjusts to the medication. Consult your doctor if they persist or if you are concerned.
- Low blood platelets
- Fatigue
- Peripheral neuropathy (tingling and numbness of feet and hands)
- Psychiatric disturbances
- Nausea
- Vomiting
- Loss of appetite
- Fever
- Anemia (low number of red blood cells)
- Diarrhea
- Decreased appetite
- Decreased white blood cell count (neutrophils)
- Constipation
WARNING & PRECAUTIONS
- Driving
Bortetrust 2 Injection may have negative effects that impair your ability to drive.
Bortetrust 2 Injection may produce fatigue, dizziness, fainting, or impaired vision, which may impair your driving abilities.
- Kidney
In patients with severe kidney disease, Bortetrust 2 Injection should be used with caution. Bortetrust 2 Injection dosage may need to be adjusted. Please consult your physician.
There is little data on the use of Bortetrust 2 Injection in these individuals.
- Liver
In patients with liver problems, Bortetrust 2 Injection should be used with caution. Bortetrust 2 Injection dosage may need to be adjusted. Please consult your physician.
- Pregnancy
Bortetrust 2 Injection should not be used during pregnancy because there is clear evidence of danger to the developing infant. However, if the advantages outweigh the hazards, the doctor may seldom prescribe it in life-threatening conditions. Please consult your physician.
Fedelty Health Care is a  Bortezomib third-party manufacturer, bulk pharma exporter, and pharmaceutical contract manufacturer operating businesses in Venezuela, Saudi Arabia, Cambodia, Oman, Brazil, Lebanon, Chile, Peru, Cuba, and Fiji. Other services they provide are hospital supply, government supply, named patient supply, cold chain supply, and drop shipping.
